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Abstract: Aquaporins (AQPs) are expressed in the uterus, playing a physiological role during
pregnancy. An osmotic pathway—through AQP5—may modify the transient potential vanilloid 4
(TRPV4) function and uterine contraction. Our aim was to determine the role of TRPV4 antagonist
citral in the regulation of pregnant uterine contraction. In vitro uterine contractions were evoked by
KCl and the response was modified with citral. The expressions of TRPV4 and AQP5 were measured
by RT-PCR and Western blot techniques. The lengths of gestational periods were determined in
normal and LPS-induced preterm births after citral treatment, in vivo. Citral significantly decreased
the uterine contraction on day 22 of pregnancy. AQP5 expression significantly increased after citral
incubation; however, TRPV4 expression did not show significant changes. After citral pretreatment,
the gestational period was extended both in normal and LPS-induced preterm births. Our results
suppose that the downregulation of AQP5 may initiate hypertonic stress, activating TRPV4 the
uterine contraction on the last day of the gestational period. The putative cooperation between AQP5
and TRPV4 may open a novel target to treat or prevent preterm birth.
Keywords: aquaporin 5; TRPV4; citral; pregnancy; preterm birth
1. Introduction
Aquaporins (AQPs) are crucial for water and small solute transport across physio-
logical barriers. Several AQP families have already been identified (AQP0 to AQP12) [1].
AQPs play role during gestational period including parturition, myometrial contractility,
and cervical ripening [2]. In our previous studies, AQP5 expression was found to be pre-
dominant during pregnancy in rats, although it was significantly downregulated at the last
gestational day. Moreover, AQP5 was upregulated by oxytocin [3] and its expression was
estrogen and progesterone dependent in the uteri of late-term rats [4]. It is supposed that
at the end of pregnancy the intensity of the uterine contractions has an inverse correlation
with the expression of the uterine AQP5.
The uterine Ca2+ level is essential for contractions, the myometrial Ca2+ influx is the
main drive for spontaneous rhythmic contractions [5]. Transient receptor potential (TRP)
ion channels are nonselective cation membrane channels. The TRP subfamily transient
receptor potential vanilloid (TRPV) channels are permeable to calcium, magnesium, and
sodium [6]. TRPV4 is the fourth cloned member of the TRPV subfamily reported as a
modulator of uterine contractility in rats [7,8]. TRPV4 can be activated by diverse stimuli,
including osmotic or mechanical stimuli, warm temperature, phorbol ester derivatives,
products of arachidonic acid breakdown or feedback regulation by Ca2+ [9]. As the promi-
nent co-localization of TRPV4 and AQP4 in retinal Müller glia cells was earlier identified
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by Ryskamp DA et al. [10], and we also determined the co-expression of TRPV4 and AQP5
in late-pregnant rat uterine tissue [7].
Citral (3,7-dimethyl-2,6-octadienal) is the major aromatic component of lemongrass
oil. It is commonly used in daily life; for instance, as a flavor to intensify taste, or as a
fragrance or as a repellent. It exhibits various pharmacological effects, such as a hepato-
protective effect in nonalcoholic fatty liver disease or an antimicrobial effect, but it also
has immunomodulatory and antihyperalgesic effects [8,11–13]. Citral produces a relaxant
effect on K+ and phenylephrine-induced contractions of isolated aorta rings in rats [14].
Furthermore, it is a well-known antagonist for TRPV4 [15].
The aim of our study was to investigate the effect of citral on the cooperation of AQP5
and TRPV4 in the late-pregnant rat uterus in vitro and in vivo to identify their mutual
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Figure 1. The su mary of the experimental model for the citral-treated rats. After the treatments,
animals were involved both into in vitro and in vivo studies.
2. Materials and Methods
2.1. Housing and Handling of the Animals
The animals were treated in accordance with the European Communities Council
Directive (2010/63/EU) and the Hungarian Act for the Protection of Animals in Research
(Article 32 of Act XXVIII). All experiments involving animal subjects were carried out
with the approval of the National Scientific Ethical Committee on Animal Experimentation
(registration number: IV/2767/2020). Sprague–Dawley rats (Animalab Ltd., Vác, Hungary)
were kept at 22 ± 3 ◦C; the relative humidity was 30–70% and the light/dark cycle was
12/12 h. The animals were maintained on a standard rodent pellet diet (INNOVO Ltd.,
Gödöllő, Hungary) with tap water available ad libitum. The rats were terminated by
CO2 inhalation.
2.2. Mating of the Animals
Mature (10 weeks old), female (180–200 g) and male (240–260 g) Sprague-Dawley
rats were mated in a mating cage before dawn. Within 4 h after the potential mating,
vaginal smears were taken and investigated under the microscope (magnification rate
1000×). If sperms or vaginal plugs were found, the female rats were separated as first-day
pregnant animals.
2.3. Experimental Mode
Figure 1 summarizes our experimental model. The rats got in vivo citral treatments
and then their uteri were involved into in vitro studies. Additionally, a group of treated
rats were allowed to deliver their pups to measure the effect of citral treatment on the
length of gestational period.
2.4. In Vitro—Isolated Contractility Study
The uteri of 22-day pregnant Sprague-Dawley rats were dissected, the fetuses were
removed, and the uteri were sliced into 0.5-cm-long rings. The smooth muscle tissues were
mounted vertically in an organ bath containing 10 mL of de Jong solution (composition
in mM: 137 NaCl, 3 KCl, 1 CaCl2, 1 MgCl2, 12 NaHCO3, 4 NaH2PO4, 6 glucose, pH 7.4).
The temperature of the organ bath was maintained at 37 ◦C with a continuous carbogen
(95% O2 + 5% CO2) supply.
The initial tension of the uterine rings was set about 1.5 g, the equilibration time was
60 min with a buffer change every 15 min. The contractions of the 22-day myometrial rings
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were measured with a gauge transducer (SG-02) and recorded with a SPEL Advanced
ISOSYS Data Acquisition System (MDE Ltd., Budapest, Hungary). The rhythmic uterine
contractions were elicited by 25 mM KCl and the cumulative concentration-response curve
of citral (10−8–10−2 M) was obtained.
2.5. Studies with Citral Pretreatment
The 22-day pregnant uterus samples were incubated in the isolated organ bath cham-
bers with 10 µM citral for 2 h. After citral incubation, the uteri were removed for RT-PCR
and Western blot measurements.
2.6. In Vivo Studies—Investigation of the Length of the Gestational Period
The animals were divided into 6 groups (n = 6–8): (1) intact pregnant rats on day 22
of pregnancy (normal term labor, n = 16); (2) pregnant rats, orally treated with olive
oil, as a vehicle control, on days 18–22 once daily; (3) pregnant rats, orally treated with
citral (240 mg/kg [3], administered by oral gavage; in olive oil vehicle; Sigma-Aldrich,
Budapest, Hungary) on days 18–22 once daily; (4) pregnant rats treated with LPS
(50 µg/animal, intraperitoneally; Sigma Aldrich, Hungary) on day 18 of pregnancy to
induce preterm birth on day 20 [16]; and (5) pregnant rats treated with LPS on day 18 and
citral on days 18–22 once daily. The administration protocol is outlined in Table 1. The
rats were closely observed for any signs of preterm delivery (e.g., decreased movement,
nest-building behavior or vaginal bleeding). The beginning of labor was defined by the
delivery of the first pup.
Table 1. Treatment protocol of late-pregnant rats. LPS: bacterial lipopolysaccharide; P.O.: orally;
I.P.: intraperitoneally.
Group Treatment Daily Dose Dosing Route
1 - - -
2 olive oil 1 mL P.O.
3 citral 240 mg/kg P.O.
4 LPS 50 µg/animal I.P.
5 LPS + citral 50 µg/animal LPS + 240 mg/kg citral I.P. + P.O.
2.7. RT-PCR Studies
Tissue isolation. Pregnant uteri samples were placed in RNAlater Solution (Sigma-
Aldrich, Hungary), then stored at −75 ◦C until the extraction of total RNA.
Total RNA preparation from tissue. Total cellular RNA was isolated by extraction with
guanidinium thiocyanate-acid-phenol-chloroform by the protocol of Chomczynski and
Sacchi [17]. After precipitation with isopropanol, the RNA was washed with 75% ethanol
and resuspended in diethyl pyrocarbonate-treated water. RNA purity was measured at an
optical density of 260/280 nm with BioSpec Nano (Shimadzu, Kyoto, Japan); all samples
exhibited an absorbance ratio in the range of 1.6–2.0. RNA quality and integrity were
assessed by agarose gel electrophoresis.
Real-time quantitative reverse transcription-PCR (RT-PCR). Reverse transcription and
amplification of the PCR products were performed by using the TaqMan RNA-to-CT-Step
One Kit (Thermo Fisher Scientific, Budapest, Hungary) and an ABI StepOne Real-Time
cycler. Reverse-transcriptase PCR amplifications were performed as follows: at 48 ◦C for
15 min and at 95 ◦C for 10 min, followed by 40 cycles at 95 ◦C for 15 s and at 60 ◦C for 1 min.
The samples of qPCR experiments contained “no-template” control or RNA samples from
non-treated and treated uterus. The generation of specific PCR products was confirmed
by melting curve analysis. The following primers were used: assay ID Rn00562837_m1
for the Aqp5 water channel, Rn00576745_m1 for Trpv4 and Rn00667869_m1 for β-actin as
endogenous control (Thermo Fisher Scientific, Hungary). All samples were run in triplicate.
The fluorescence intensities of the probes were plotted against PCR cycle number. The
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amplification cycle displaying the first significant increase in the fluorescence signal was
defined as the threshold cycle (CT).
2.8. Western Blot Analysis
The uterine tissues from pregnant animals (tissue between two implantation sites)
were homogenized using a Micro-Dismembrator (Sartorius AG, Göttingen, Germany) and
centrifuged at 5000× g for 15 min at 4 ◦C in RIPA Lysis and Extraction Buffer (Thermo
Fisher Scientific, Hungary) with protease and phosphatase inhibitor cocktail. Total pro-
tein amounts from supernatant were determined with spectrophotometry (BioSpec-nano,
Shimadzu, Japan).
25 µg of protein per well was used for electrophoresis on 4–12% NuPAGE Bis-Tris Gel
in XCell SureLock Mini-Cell Units (Thermo Fisher Scientific). Proteins were transferred
from gels to nitrocellulose membranes by iBlot Gel Transfer System (Thermo Fisher Sci-
entific). Antibody binding was detected with the WesternBreeze Chromogenic Western
blot immunodetection kit (Thermo Fisher Scientific, Hungary). The blots were incubated
overnight, at 4 ◦C, on a shaker with AQP5 (cat. no AB-15858, 1:200, Sigma-Aldrich), β-actin
(cat. no bs-0061R, 1:200, Bioss Antibody) and TRPV4 (cat. no OSR00136W 1:200, Thermo
Fisher Scientific) polyclonal primary antibody in the blocking buffer. The incubation of
the secondary antibody solution was carried out based on the protocol of WesternBreeze®
Chromogenic Immunodetection Kit. Images were taken with the EDAS290 imaging system
(Kodak Ltd., Budapest, Hungary), the optical densities of immunoreactive bands were
determined with Kodak 1D Images analysis software. Optical densities were expressed as
arbitrary units after the subtraction of the local area background.
2.9. Statistical Analysis
Statistical analyses were performed with the Prism 4.0 software (Graphpad Software
Inc. San Diego, CA, USA). All data were analyzed by one-way ANOVA, followed by Dun-
nett multiple comparison test or Student’s t-test, and each is presented as the mean ± SEM.
Significance was accepted at p < 0.05.
3. Results
3.1. Contractility Studies
Citral (10−8–10−2 M) inhibited the KCl-evoked contractile response in the 22-day
pregnant rat uteri (Figure 2). In low (10−8–10−5 M) concentrations its relaxant effect
was almost nonsignificant; however, in high concentrations (10−4–10−2 M) its action was
increased steeply. The maximum relaxant effect of citral was 62.9% ± 2.5, while the EC50
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Figure 2. Cumulative concentration-response curve of citral (10−8–10−2 M) on 22-day pregnant rat
uteri. The alteration in contraction wa determined by the rea under the curve (AUC) method and
expressed in % ± S.E.M. as compared with the AUC of KCl-evoked control contractions. n = 6.
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3.2. Studies with Citral Pretreatment
AQP5 and TRPV4 mRNA and protein expression were measured in the 22-day preg-
nant uteri after citral treatment (10 µM for 2 h), in vitro. AQP5 expression significantly
increased after citral incubation compared to the control (Figure 3A,B). However, the
changes in TRPV4 expression were not significant (Figure 3C,D).
Life 2021, 11, x FOR PEER REVIEW 5 of 9 
AQP5 and TRPV4 mRNA and protein expression were measured in the 22‐day preg‐
nant uteri after citral treatment (10 μ for 2 h),  in vitro. AQP5 expression significantly
increased  after  citral incubation  compared to  the  control  (Figure 3A‐B). However, the 
changes in TRPV4 expression were not significant (Figure 3C– ). 
Figure 3. Changes in AQP5 mRNA (A) and protein (B, 35 kDa) and TRPV4 mRNA (C) and protein 
(D, 105 kDa) expression of on gestational day 22 in pregnant rat uteri after citral treatment, in vitro.
‐actin (43 kDa) was used as a loading control. C: control uterus, Cit: citral‐treated uterus, ns > 0.05; 
*** p < 0.001; compared to the control uterus sample. n = 6. 
3.3. Effect of Citral Treatment on the Length of the Gestational Period 
The time of birth of the control rats mostly occurred during the morning (t = 11.9 ± 





The time of labor in inflammatory‐induced preterm birth (LPS) was during the night 
(t = 0.8 ± 1.5 h) on day 20. No significant changes were determined in the time of labor 




Figure 3. Changes in AQP5 mRNA (A) and protein (B, 35 kDa) and TRPV4 mRNA (C) and protein
(D, 105 kDa) expre sion of on gestational day 2 in pregnant rat uteri after citral treatment, in vitro.
β-actin (43 kDa) was used as a loading control. C: control uterus, Cit: citral-treated uterus, ns > 0.05;
*** p < 0.001; compared to the control uterus sample. n = 6.
3.3. Effect of Citral Treatment on the Length of the Gestational Period
The ti e f irt of the control rats mostly occurred during the morning (t = 11.9± 0.5 h)
on the 22nd day of pregnancy. The length of the gestational period significantly increased
(mean time of birth on day 22: 15.9 ± 0.9 h) after vehicle (olive oil) treatment. The
gestational period was further extended after citral treatment (t = 28.6 ± 2.3 h) in normal
pregnancy (Figure 4A). During the experiments Side effects or toxic effects ere not
observed in any of the groups.
The time of labor in inflammatory-induced preterm birth (LPS) was during the night
(t = 0.8 ± 1.5 h) on day 20. No significant changes were determined in the time of labor
after vehicle treatment in LPS rats (t = 1.6 ± 1.0 h). The gestational period of LPS-treated
rats was significantly longer, the time of delivery was extended to the dawn of the 22nd
day of pregnancy (t = 54 ± 5.5 h) after citral treatment (Figure 4B).



































Figure 4. (A) Changes in the time of birth of normal pregnancy in C control, O: olive oil-treated and
Cit: citral-treated rats. (B) Changes in the time of birth in bacterial lipopolysaccharide (LPS)-induced
preterm birth, bacterial lipopolysaccharide and olive oil (LPS + O) or bacterial lipopolysaccharide
nd citral (LPS + Cit)-treated animals. ns > 0.05, * p < 0.05, *** p < 0.001; compared to the control or
LPS-treated animals.
4. Discussion
The annual number of premature babies is estimated 15 million [18] and preterm birth
(PTB) is responsible for most of the infant mortality and morbidity. Since the causes of
PTB are widely varying, therefore the identification and prevention of PTB is very difficult,
sometimes impossible and their low chance to reduce the PTB rate in the near future. The
solutions may arise by interdisciplinary efforts, gaining a better understanding of the
pathomechanism of PTB [19].
In our previous study, an inverse correlation was confirmed between the AQP5
level and myometrial contraction, a reduced uterine AQP5 expression was accompanied
with enhanced contractility. Several signal transduction mechanisms were identified to
regulate AQP expressions in animals. An osmotic pathway, in which the changes in
AQP5 expression are presumed to influence the osmotic milieu in late-pregnant uterine
tissue, may lead to the alteration of the osmotic-sensitive TRPV4 channel modifying the
myometrial Ca2+ level. This pathway was confirmed by the irreversible correlation between
the expression of TRPV4 and AQP5 in the late-pregnant rat uterus [7].
Currently, in vivo experimental tests for AQPs are very limited because subtype-
selective agents are not available. Hence we examined this system from the TRPV4 -“side”
using a well-tolerated, natural plant product, citral.
Citral is an antioxidant, inhibitor of nuclear factor kappa B (NF-κB) and cyclooxygenase-2
(COX-2) and activator of peroxisome proliferator-activated receptor (PPAR)-α and γ. Be-
side these actions, it elicits a sustained inhibition of TRP channels of sensory neurons
(like TRPV1–3 and TRPM8), and a short-term blockade of TRPV4 and TRPA1 [20]. In
addition, it is an odorous ingredient in beverages, foods, and cosmetics. A novel study
highlighted that citral has potential therapeutic significance as a smooth muscle relaxant
and local anesthetic, as it promotes relaxation in tracheal and aortic smooth muscles and
inhibits nerve excitability in animal models [21]. Since our recent work involved an in vivo
experiment with pregnant rats. Therefore, we had to choose a TRPV4 inhibitor that is safe
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for pregnant animals, and its dosage and pharmacokinetic parameters are available. Citral
met with these requirements [22]. Unfortunately, none of the available selective TRPV4
blockers e.g., GSK 2193874, RN-1734 has pharmacokinetic, gestational safety or in vivo
dosage data. Therefore, we could not involve them in our in vivo experiment.
In our recent study, citral treatment-induced dose-dependent uterus relaxation in vitro
and enhanced the length of normal pregnancy. Surprisingly, olive oil significantly extended
the length of normal gestational period, but such an effect of citral was even higher. The
uterus relaxant effect of the active compound of olive oil (oleocanthal) has been proved
by the inhibition of calcium/PGF2-induced uterine hypercontraction [23]. Oleic acid
supplementation favors basal PGE2 production in both the maternal endometrium and
the fetal allantochorion. In the maternal endometrium, oleic acid increased the ratio of
PGE2:PGF2α and antagonized the oxytocin-induced PG production. It is very probable
that elevated oleic acid level may have an impact on parturition including the initiation and
the progression as well [24]. This effect of olive oil could not be detected in LPS-induced
preterm birth. Endotoxin treatment in rats induces systemic inflammatory responses
both in the mother and the fetus [25]. In parallel, downregulation of AQP5 in LPS- and
hormonally induced preterm birth were detected, too [4].
The anti-inflammatory and tocolytic effects of citral have already been investigated
in vitro, it increased the cAMP level in human myometria [26]. An alternative pathway was
investigated in our studies via the cooperation of AQP5 and TRPV4. External Ca2+ entry
via voltage-gated calcium channels is essential for myometrial contractions. However, other
calcium channels are also important in the contractile response. One potential candidate
is the TRPV4 channel [27]. TRPV4 channel activity modulates uterine contractility in
murine models [28] and human myometrial tissues, in vitro [29]. The functional interaction
between the selective water channel AQP5 and ion channels, such as TRPV4, closely
participates in the regulation of osmotic homeostasis. In salvia gland cells, TRPV4 has a
proved interaction with AQP5. In lack of AQP5, the hypotonicity generated calcium flow
via TRPV4 was significantly reduced and subsequently the decrease in regulatory volume
ceased [30,31]. TRPV4 plays a role in the hypotonic reduction of AQP5, including the
control of extracellular calcium. This is proved by the increase in intracellular calcium after
hypotonic stimulation, and a decrease in AQP5 in the presence of TRPV4 stimulator [32].
Based on our earlier result, we assume that high AQP5 expression from pregnancy
day 18 [3] resulted in a hypotonic cytoplasm in uterus cells, which triggers smooth muscle
cell membrane stretching and activates calcium influx through TRPV4. This mechanism
is confirmed by the colocalization of AQP5 and TRPV4 in late-pregnant rat uterus and
the increasing expression of TRPV4 at the time of labor [7]. As a result of cell volume
regulation, AQP5 expression decreased on the last day of pregnancy.
The expression and activation of TRPV4 are modified along with volume expansion.
Citral (TRPV4 antagonist) treatments suppressed cell volume expansion, thereby influenced
AQP5 expression, inhibited uterus contraction and extended the duration of pregnancy
in rat.
Our results give basic information about the role of AQP5 and TRPV4 in delivery and
may provide new insight into the unrevealed process of preterm delivery. The clinical trans-
lation of our results might open a new possibility for the therapy and prevention of preterm
birth targeting AQP5 and TRPV systems. Further preclinical studies are required with
selective TRPV4 inhibitors; however, those studies must be preceded by pharmacokinetic
and gestational safety measurements of these selective blockers in pregnant rats
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